Cargando…

A Live Vector Expressing HPV16 L1 Generates an Adjuvant-Induced Antibody Response In-vivo

BACKGROUND: The association between human papillomavirus (HPV) infections and cervical cancer has suggested the design of prophylactic and therapeutic vaccines against genital warts. The HPV capsid has made of two L1 and L2 coat proteins that have produced late in viral infections. Regarding to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirbaghaee, Zeinab, Bolhassani, Azam, Mirshafiey, Abbas, Motevalli, Fatemeh, Zohrei, Negar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shahid Beheshti University of Medical Sciences 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736072/ https://www.ncbi.nlm.nih.gov/pubmed/26855722 http://dx.doi.org/10.17795/ijcp-3991

Ejemplares similares

A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins
por: Panahi, Heidar Ali, et al.
Publicado: (2018)

Development of HPV(16,18,31,45) E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
por: Namvar, Ali, et al.
Publicado: (2020)

Enhancement of potent immune responses to HPV16 E7 antigen by using different vaccine modalities
por: Bolhassani, Azam, et al.
Publicado: (2011)

Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women
por: Ramezani, Amitis, et al.
Publicado: (2019)

Current and future direction in treatment of HPV-related cervical disease
por: Khairkhah, Niloofar, et al.
Publicado: (2022)

In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate
por: Davoodi, Saba, et al.
Publicado: (2021)

Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum
por: NASIRI, Vahid, et al.
Publicado: (2016)

Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model
por: Abbasifarid, Elnaz, et al.
Publicado: (2021)

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

In Vitro Sensitivity of Leukemia Cells to Propranolol
por: Hajighasemi, Fatemeh, et al.
Publicado: (2009)

In Vitro Effects of Propranolol on T Helper Type 1 Cytokine Profile in Human Leukemic T Cells
por: Hajighasemi, Fatemeh, et al.
Publicado: (2016)

Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
por: Shirbaghaee, Zeinab, et al.
Publicado: (2022)

Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
por: Shirmohammadi, Masoumeh, et al.
Publicado: (2021)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Enhanced gene delivery in tumor cells using chemical carriers and mechanical loadings
por: Hadi, Amin, et al.
Publicado: (2018)

Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route
por: Vo, Trinh Phuong, et al.
Publicado: (2022)

Enhanced transient expression of an anti-CD52 monoclonal antibody in CHO cells through utilization of miRNA sponge technology
por: Pairawan, Morvarid Sadat, et al.
Publicado: (2019)

In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine
por: Namvar, Ali, et al.
Publicado: (2019)

B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs
por: Kardani, Kimia, et al.
Publicado: (2020)

Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines
por: Bolhassani, Azam
Publicado: (2022)

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
por: Szarewski, Anne, et al.
Publicado: (2013)

Which one of the thermal approaches (heating DNA or cells) enhances the gene expression in mammalian cells?
por: Milani, Alireza, et al.
Publicado: (2021)

Natural Killer Cells and Their Role in Rheumatoid Arthritis: Friend or Foe?
por: Shegarfi, Hamid, et al.
Publicado: (2012)

Immunoinformatics studies of heat shock proteins 27 and 70: Development of potent therapeutic vaccine constructs against human papillomavirus-related cancers
por: Rezaei, Fatemeh, et al.
Publicado: (2023)

Generation of affibody molecules specific for HPV16 E7 recognition
por: Xue, Xiangyang, et al.
Publicado: (2016)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Construction and detection of the tissue-specific pINV-HPV16 E6/7 vector
por: GAO, HUI, et al.
Publicado: (2015)

Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
por: Wan, Bing, et al.
Publicado: (2022)

Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+ Cancer
por: Peng, Shiwen, et al.
Publicado: (2015)

Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial
por: Lehtinen, Matti, et al.
Publicado: (2019)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches
por: Kardani, Kimia, et al.
Publicado: (2021)

Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates
por: Hadi, Amin, et al.
Publicado: (2021)

Erratum to “Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates”
por: Hadi, Amin, et al.
Publicado: (2021)

Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2018)

Results of post-laparoscopic cholecystectomy duplex scan without deep vein thrombosis prophylaxis prior to surgery
por: Pakaneh, Mohammad Ali, et al.
Publicado: (2012)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Expression and Characterization of Two DNA Constructs Derived from HIV-1-vif in Escherichia coli and Mammalian Cells
por: Zamani, Fatemeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r676dcnalobq783hkjehmq9hu0